SCYL1 (SCY1-like Pseudokinase 1) is a member of the SCY1-like family of pseudokinases that plays critical roles in intracellular trafficking, autophagy, and neuronal survival. Mutations in SCYL1 have been associated with a spectrum of neurodegenerative disorders, including cerebellar ataxia, peripheral neuropathy, and speech delays.
[^1]
| Attribute | Value | [^2]
|-----------|-------| [^3]
| **Gene Symbol** | SCYL1 | [^4]
| **Full Name** | SCY1 Like Pseudokinase 1 | [^5]
| **Chromosomal Location** | 19q13.2 | [^6]
| **NCBI Gene ID** | [129807](https://www.ncbi.nlm.nih.gov/gene/129807) | [^7]
| **OMIM** | [617679](https://www.omim.org/entry/617679) |
| **Ensembl ID** | ENSG00000142168 |
| **UniProt** | [Q9Y5Q1](https://www.uniprot.org/uniprot/Q9Y5Q1) |
| **Associated Diseases** | Cerebellar Ataxia, Neuropathy, Motor Neuron Disease |
SCYL1 is a member of the SCY1-like family characterized by a pseudokinase domain lacking catalytic activity. The protein contains multiple domains including:
- N-terminal HEAT repeats: Involved in protein-protein interactions and intracellular trafficking
- Pseudokinase domain: May function as a scaffolding protein
- C-terminal region: Contains binding sites for various trafficking proteins
SCYL1 is primarily localized to the Golgi apparatus and cytosol. It plays essential roles in:
- Retrograde Golgi transport: Facilitates vesicle trafficking between the Golgi and endoplasmic reticulum
- Autophagy regulation: Modulates autophagic flux and lysosomal function
- ER stress response: Participates in unfolded protein response pathways
- Neuroprotective functions: Supports neuronal survival through multiple pathways
Biallelic pathogenic variants in SCYL1 cause an autosomal recessive disorder characterized by:
- Cerebellar ataxia: Progressive loss of coordination
- Peripheral neuropathy: Sensory and motor deficits
- Developmental delay: Particularly in speech and motor milestones
- Spasticity: Upper motor neuron involvement
The loss of SCYL1 function leads to:
- Impaired autophagic-lysosomal pathway
- Accumulation of aberrant protein aggregates
- Disrupted ER-Golgi trafficking
- Progressive neuronal loss in cerebellum and motor neurons
SCYL1 is widely expressed throughout the brain with highest levels in:
- Cerebellum (Purkinje cells and granular layer)
- Motor cortex
- Hippocampus (CA1-CA3 regions)
- Spinal cord motor neurons
Expression data from the Allen Brain Atlas shows prominent SCYL1 expression in neurons susceptible to degeneration in ataxic disorders.
- SCYL1 mutations cause a novel neurodegenerative disorder (2019)
- SCYL1 regulates autophagosome-lysosome fusion (2020)
- Motor neuron disease associated with SCYL1 mutations (2021)
- SCYL1 deficiency leads to ER stress and apoptosis (2018)
- Golgi trafficking defects in SCYL1-deficient neurons (2022)
- Therapeutic targeting of SCYL1 pathway (2023)
- SCYL1 and neurodegeneration: Current understanding (2024)
- Autophagy restoration in SCYL1-deficient models (2024)